Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.
LEP Biomedical is developing a dissolvable implant designed to replace post-operative eye drops following glaucoma surgery. The device aims to improve patient compliance during recovery, addressing a significant driver of surgical failure rates that can reach 40%. The implant delivers medication over weeks without requiring patient self-administration.
Nyxoah, a Belgium-based medical device company, has implanted the first patient in its BREATHE post-approval study of the Genio system for obstructive sleep apnea. The Genio is an implantable neurostimulation device designed to treat OSA by stimulating the hypoglossal nerve.
Philips launched the eV14-2v transvaginal transducer, expanding its ultrasound portfolio for obstetrics and gynecology applications. The transducer is designed for use in reproductive health imaging procedures.
HR HealthCare launched the Liv Pre-lubricated Intermittent Catheter, a device designed for female self-catheterization to support bladder health management. The product addresses a specific segment of the intermittent catheterization market with pre-lubricated technology.
Selio Medical announced FDA clearance for a hydrogel device designed to seal puncture sites during CT-guided lung biopsies, preventing pneumothorax complications that occur in up to one-third of the 800,000+ procedures performed annually in the U.S. The device addresses a significant clinical and economic burden associated with this common diagnostic procedure.
Abbott presented longer-term clinical data for its TactiFlex Duo ablation catheter at ESC 2026, a dual-modality device combining pulsed-field and radiofrequency ablation for atrial fibrillation treatment. The data demonstrated positive outcomes with the dual-technology approach, which offers clinicians flexibility in catheter selection during AF procedures.
Fractyl Health's Revita system, a minimally invasive hydrothermal ablation device, demonstrated efficacy in maintaining up to 84% of weight loss achieved with GLP-1 medications one year after discontinuation. The single-use catheter targets the duodenal mucosa in the proximal small intestine. The device represents a potential adjunctive approach to weight management following GLP-1 therapy cessation.
Heartflow presented data at ESC 2026 showing its fractional flow reserve (FFR) technology reduced unnecessary invasive coronary angiography (ICA) by 44% at one year, compared to 22% reduction with coronary CT angiography (CCTA) alone. The tool integrates with existing imaging workflows to guide intervention decisions in coronary artery disease assessment.
Philips and Imricor Medical Systems launched a new iMR lab solution designed for cardiac interventions. The system integrates MR imaging with interventional capabilities to support real-time guidance during cardiac procedures, combining Philips' imaging platform with Imricor's MR-compatible cardiac technology.
Datavant launched a provider exchange platform designed to digitize medical record requests, replacing traditional fax-based workflows. The system provides real-time visibility into request status and reduces administrative burden on clinical staff by accelerating retrieval from days to hours.
Axoft has launched Fleuron WISE, a polymer designed to reduce optical distortions during high-resolution imaging of aqueous biological samples. The material targets improved image quality in microscopy and diagnostic imaging applications where sample clarity is critical.
Medical Guardian launched Guardian Flex, a wearable device designed for older adults that provides emergency alert capabilities. The product integrates into daily routines and targets the aging population seeking personal safety and emergency response solutions.
Researchers at UC San Diego developed a wearable smart ring that uses finger sweat to monitor six biomarkers: glucose, ketones, vitamin C, uric acid, lactate, and alcohol. The device employs an osmotic hydrogel to extract and analyze sweat composition, with findings published in Nature Communications. The technology represents a new class of non-invasive continuous monitoring wearable for personal health tracking.
BD has launched the HemoSphere Stream Module, a noninvasive continuous blood pressure monitoring technology. Tim Patz, BD's Worldwide President of Advanced Patient Monitoring and former Edwards Lifesciences executive, led the product introduction. The technology reflects industry movement toward less-invasive patient monitoring solutions.
Galmed subsidiary Colospan has completed a feasibility study of an intraoperative platform designed to assess colon tissue quality during surgical procedures. The technology represents a new diagnostic tool for real-time tissue evaluation in colorectal surgery.
Lumafield used industrial X-ray CT scanning to provide a detailed internal examination of Medtronic's PillCam capsule endoscope, a swallowable diagnostic device used to visualize portions of the digestive tract unreachable by traditional endoscopy and colonoscopy since its 2001 introduction by Given Imaging.
Researchers at University of Illinois Urbana-Champaign have developed a wearable device designed to detect early signs of dialysis access point failure. The technology aims to alert patients and clinicians to potential complications before they become critical, reducing unplanned dialysis interruptions and improving vascular access management.
Nanochon has received approval from Panama's Ministry of Health to initiate a first-in-human clinical trial of its Chondrograft implant, a knee cartilage device. The trial represents an early-stage advancement for the company's regenerative orthopedic technology, marking progression toward potential commercialization in the region.
Bal Seal Engineering announced that its SP400HT PTFE sealing material has completed biocompatibility validation to ISO 10993-5 and USP Plastic Class VI standards, as tested by independent lab NAMSA. The material expands the company's portfolio of medical-grade sealing solutions for OEM device manufacturers.
BD has completed patient enrolment in the PREVENT clinical trial evaluating Phasix Mesh for prevention of incisional hernias. The trial's conclusion of the enrolment phase marks a step toward potential regulatory submissions and commercialization decisions for the resorbable mesh product.
RenovoRx announced the first commercial clinical use of its RenovoCath device in treating a sarcoma patient. RenovoCath is a catheter-based delivery system designed for localized cancer therapy. The milestone marks initial market adoption of the device following prior regulatory or clinical milestones.
GE HealthCare launched two new breast imaging products designed to improve lesion detection in women with dense breast tissue and streamline enterprise workflows. The tools expand GE's existing breast imaging portfolio and address a clinical need in screening and diagnostic applications.
Johnson & Johnson MedTech announced its Ottava surgical robotics system following FDA de novo authorization. The system features folding arms, haptic feedback capability, and is positioned as a category-defining soft-tissue surgical platform. The company unveiled the device at the July 2026 Society of Robotic Surgery annual meeting.
Becton, Dickinson and Co. has developed a platform for noninvasive continuous blood pressure monitoring, advancing its vision of continuous patient monitoring from admission through discharge. Tim Patz, worldwide president of BD's Advanced Patient Monitoring business, leads the effort to extend monitoring capabilities across the patient care continuum.
VDyne has enrolled and treated the first patient in the TRIVITA US IDE pivotal study of its TriNova transcatheter tricuspid valve replacement system. The trial is designed to evaluate safety and efficacy of the device in patients with symptomatic tricuspid regurgitation.
Zeus announced that its PFX Flex Sub-Lite-Wall catheter liners have received Intertek certification as PFAS-free, becoming the first medical device components certified free of per- and polyfluoroalkyl substances. The certification reflects growing regulatory and customer pressure on device makers to eliminate these persistent chemicals from their products.
Labcorp launched Marker by Labcorp Genetic Health Panel, a consumer-accessible genetic test that screens for hereditary risk across more than 100 medically actionable conditions. The panel expands direct-to-consumer access to hereditary risk assessment, enabling broader screening for genetic predispositions to disease.
TE Connectivity introduced an automated 3D printing process for manufacturing catheter shafts supplied to medical device makers, replacing a manual assembly method. The new process is designed to reduce production costs and streamline manufacturing for one of the supplier's key product lines.
Dopl Technologies, a Bothell, Washington startup, is developing a robotic ultrasound platform that enables remote sonographers to perform patient imaging. The company, co-founded by Ryan James, a former Nvidia medical AI engineer, plans to expand into minimally invasive applications. The platform addresses the challenge of ultrasound access in underserved areas by allowing clinicians to operate imaging equipment remotely.
Johnson & Johnson MedTech received FDA de novo authorization for its Ottava surgical robotics system, a table-integrated soft-tissue surgery platform designed to occupy 30–50% less operating room space than traditional boom-and-cart surgical robot configurations. The system represents the first table-mounted soft-tissue robotic surgery device cleared by the FDA.
Hilo, a health technology brand developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US market. The system represents a new product entry in the remote patient monitoring and vital signs space.
Fresenius Medical Care launched TherapyWise, a cloud-based analytics platform designed to support hospital and critical care teams managing kidney replacement therapy (KRT) in the US. The platform enables real-time data analysis and clinical decision support for dialysis and renal care providers.
ARUP Laboratories launched CLARISPECT Multiple Myeloma MRD, a spectral flow cytometry assay for detecting minimal residual disease in multiple myeloma patients. The assay represents a clinical offering from ARUP's diagnostic laboratory services and is designed to support treatment monitoring and patient stratification in hematologic malignancy care.
Enable Injections' enFuse on-body injector (OBI) platform achieved its second FDA approval in July 2026 when Sanofi received clearance for an anticancer treatment using the device. The enFuse system previously secured its first combination product approval in 2023 for paroxysmal nocturnal hemoglobinuria. The platform represents a first-of-its-kind wearable drug delivery technology in the oncology space.
GE HealthCare launched a remote workflow access tool for MIM (medical imaging management) systems designed to enable imaging workflow collaboration among specialist teams, particularly in oncology. The tool is intended to streamline coordination between different departments working with imaging data.
BRIJ Medical has commercially launched BRIJ-SEAL, a wound sealant designed to seal and protect surgical incisions following surgery. The product addresses post-operative wound management in the operating room and recovery settings.
VahatiCor has developed the A-Flux, an investigational nitinol implant designed to treat coronary microvascular dysfunction (CMD), a condition in which coronary arteries fail to dilate properly, restricting blood flow to the heart and causing chest pain, shortness of breath, and fatigue without major arterial blockages. The implant addresses a patient population currently lacking targeted interventional options.
HiArc will exhibit its Ctrl platform at ADLM 2026 in Anaheim in July. Ctrl is an integrated hardware and software platform designed to accelerate development of medical devices and diagnostic systems. The company will showcase the offering at booth 3555.
Microbot Medical received FDA 510(k) clearance in September 2025 for its Liberty robotic system, a fully disposable, single-use endovascular navigation device designed for remote delivery and manipulation of guidewires and catheters. The company is positioning Liberty as a contender in the telesurgery market, particularly for stroke intervention applications.
A new 3D printing technology enables lower extremity surgeons to design and customize surgical solutions rather than rely on standard off-the-shelf approaches. The technology positions surgeons as architects of patient restoration, allowing more precise surgical planning and implant customization for orthopedic procedures.
84 older new products stories available.